Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 1658


Myth Replacement Therapy: MPs Debate the Science of Mitochondriaby Dr Ted MorrowBioNewsSeptember 8th, 2014There are clearly misconceptions about mitochondrial genetics repeated during the debate that are not supported by current scientific evidence.
Editing DNA Could be Genetic Medicine Breakthrough[References CGS]by Stephanie M. LeeSan Francisco ChronicleSeptember 7th, 2014A new way to make powerful changes at will to the DNA of humans, other animals and plants, much like how a writer changes words in a story, could usher in a transformation in genetic medicine.
Body Upgrades may be Nearing Reality, but Only for the Richby Ian SampleThe GuardianSeptember 5th, 2014Israeli historian Yuval Noah Harari says expensive human enhancements will lead to a society more unequal than ever.
Australian Federal Court Rules Isolated Genetic Material can be PatentedThe GuardianSeptember 4th, 2014The decision is likened to ‘being allowed to patent oxygen’, as critics warn of serious repercussions for medical research.
Where is the brain in the Human Brain Project?by Yves Frégnac & Gilles LaurentNatureSeptember 3rd, 2014Europe's €1-billion science and technology project needs to clarify its goals and establish transparent governance.
On the Horns of the GMO Dilemmaby Antonio RegaladoMIT Technology ReviewSeptember 2nd, 2014Can genome-editing technology revive the idea of genetically modified livestock?
Synthetic biology goes for scaleby Joanna GlasnerReutersSeptember 2nd, 2014Synthetic biology, which uses engineered gene sequences to create new biological systems and devices, used to be a subject for futurists and sci-fi writers, but now is attracting large investments.
Stem cell industry's 'huge development' in Bay Areaby Stephanie M. LeeSan Francisco ChronicleAugust 29th, 2014Almost three years after Geron shut down the world's first clinical trial of a therapy using embryonic stem cells, a subsidiary of another Bay Area company is reviving the work.
Stem cell therapy a primitive artby Jill MargoFinancial ReviewAugust 27th, 2014A loophole in Australian regulations means people can be given stem cell therapy for virtually anything, providing their own stem cells are harvested and then used in the process. But much can go wrong.
Will Lowering The Price Of Genetic Testing Raise The Cost Of Medical Care?by Peter UbelForbesAugust 25th, 2014The days of affordable genomic sequencing are rapidly approaching. But will such testing bankrupt us?
Displaying 11-20 of 1658  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760